Aptevo Therapeutics shares are trading lower after the company priced $5 million public offering of 8,064,517 shares at $0.62/ share.
Portfolio Pulse from Benzinga Newsdesk
Aptevo Therapeutics has priced a $5 million public offering of 8,064,517 shares at $0.62 per share. This has led to a decrease in the company's share price.
August 04, 2023 | 10:42 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptevo Therapeutics' share price is expected to decrease in the short term due to the pricing of its public offering.
The company's decision to price its public offering at $0.62 per share, which is likely lower than its current market price, has led to a decrease in its share price. This is because the new shares are being sold at a discount, which dilutes the value of existing shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100